These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3373589)

  • 61. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
    Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
    de la Rosa F; Garcia-Carbonero R; Passas J; Rosino A; Lianes P; Paz-Ares L
    J Urol; 2002 Jun; 167(6):2413-8. PubMed ID: 11992048
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical evaluation of adjuvant chemotherapy for high stage bladder cancer.
    Uekado Y; Hirano A; Shinka T; Ohkawa T
    Urol Int; 1991; 47 Suppl 1():123-6. PubMed ID: 1949368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study.
    Dreicer R; Messing EM; Loehrer PJ; Trump DL
    J Urol; 1990 Nov; 144(5):1123-6; discussion 1126-7. PubMed ID: 2231884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pelvic recurrence after radical cystectomy without preoperative radiation.
    Wishnow KI; Dmochowski R
    J Urol; 1988 Jul; 140(1):42-3. PubMed ID: 3379692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Case report: complete response of metastatic transitional cell carcinoma of the bladder with chemotherapy alone.
    Dougherty WE; Lynch JH; Maxted WC
    J Urol; 1984 Feb; 131(2):340-2. PubMed ID: 6538239
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Investigation of postoperative adjuvant chemotherapy in patients with transitional cell carcinoma of the upper urothelium. Nara Urooncology Research Group (NUORG)].
    Uemura H; Ozono S; Hayashi Y; Hirao Y; Okajima E; Aoyoma H; Sasaki K; Ohara S; Hashimoto M; Yoshikawa M
    Nihon Hinyokika Gakkai Zasshi; 1991 Aug; 82(8):1273-80. PubMed ID: 1921019
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advanced transitional cell bladder cancer: a treatable disease.
    Roemeling RV; Hrushesky WJ
    Semin Surg Oncol; 1986; 2(2):76-89. PubMed ID: 3331211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Adjuvant chemotherapy for high-stage and/or high-grade bladder cancer following radical cystectomy. A preliminary report].
    Uekado Y; Shinka T; Kumeda K; Hirano A; Yoshida M; Yamamoto S; Watanabe T; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1986 Mar; 77(3):466-73. PubMed ID: 3735871
    [No Abstract]   [Full Text] [Related]  

  • 72. Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.
    Yagoda A
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S9-12. PubMed ID: 6685581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report.
    Merrin C; Beckley S
    J Urol; 1978 Jan; 119(1):62-3. PubMed ID: 621817
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The management of advanced bladder carcinoma.
    Kedia KR; Gibbons C; Persky L
    J Urol; 1981 May; 125(5):655-8. PubMed ID: 7194923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intra-arterial cisplatin for bladder cancer.
    Stewart DJ; Eapen L; Hirte WE; Futter NG; Moors DE; Murphy PG; Irvine AH; Genest P; McKay DE; Evans WK
    J Urol; 1987 Aug; 138(2):302-5. PubMed ID: 3599243
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimens.
    Dexeus FH; Logothetis CJ; Samuels ML; Ayala AG; Hossan E
    J Urol; 1987 Jan; 137(1):122-5. PubMed ID: 3795354
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study.
    Mulder JH; Fossa SD; De Pauw M; Van Oosterom AT
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):111-2. PubMed ID: 7200890
    [No Abstract]   [Full Text] [Related]  

  • 79. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.
    Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP
    J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors.
    Schwartz S; Yagoda A; Natale RB; Watson RC; Whitmore WF; Lesser M
    J Urol; 1983 Oct; 130(4):681-4. PubMed ID: 6684180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.